| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |